UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035021
Receipt number R000039934
Scientific Title Effect of cereal breakfast on secondary prevention in the patients with ischemic heart disease and with arteriosclerosis
Date of disclosure of the study information 2018/12/01
Last modified on 2021/05/30 14:44:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of cereal breakfast on secondary prevention in the patients with ischemic heart disease and with arteriosclerosis

Acronym

cereal food for anti-arteriosclerosis

Scientific Title

Effect of cereal breakfast on secondary prevention in the patients with ischemic heart disease and with arteriosclerosis

Scientific Title:Acronym

the benefit of cereal food for anti-arteriosclerosis

Region

Japan


Condition

Condition

Patients who underwent coronary artery bypass surgery due to ischemic heart disease or patients who have risk factor(s) for arteriosclerosis

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Secondary prevention for ischemic heart disease due to antihypertensive effect or improve of dyslipidemia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

blood pressure

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Take 50 gram of cereal breakfast for breakfast

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients with stable condition after the surgery or patients who have risk factor(s) for arteriosclerosis

Key exclusion criteria

malignant tumor
GNRI<90
allergy for the food

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Matsushita

Organization

Juntendo University

Division name

Department of cardiovascular surgery

Zip code

113-8421

Address

2-1-1, Hongo, Bunkyo-ku Tokyo Japan

TEL

03-3813-3111

Email

saty-m@juntendo.ac.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Matsushita

Organization

Juntendo University

Division name

Department of cardiovascular surgery

Zip code

113-8421

Address

2-1-1, Hongo, Bunkyo-ku Tokyo Japan

TEL

03-3813-3111

Homepage URL


Email

saty-m@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Calbee corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Midori-juji Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University

Address

2-1-1, Hongo, Bunkyo-ku Tokyo Japan

Tel

03-3813-3111

Email

saty-m@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂医院(東京都)、緑十字クリニック(神奈川県)


Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 11 Month 26 Day

Date of IRB

2018 Year 11 Month 26 Day

Anticipated trial start date

2018 Year 12 Month 03 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 11 Month 27 Day

Last modified on

2021 Year 05 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039934


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name